Patient Scot Invests ๐Ÿด๓ ง๓ ข๓ ณ๓ ฃ๓ ด๓ ฟ (@PatientScot) header
Patient Scot Invests ๐Ÿด๓ ง๓ ข๓ ณ๓ ฃ๓ ด๓ ฟ (@PatientScot) profile picture

A Scottish investor documenting his long-term journey in the stock market. Analysing and learning every day. $OSCR $SOFI $NVO $APP $RDDT $IREN $GRAB $BMNR $KEEL

Dunfermline
Joined March 2026
Photo by Patient Scot Invests ๐Ÿด๓ ง๓ ข๓ ณ๓ ฃ๓ ด๓ ฟ (@PatientScot)Photo by Patient Scot Invests ๐Ÿด๓ ง๓ ข๓ ณ๓ ฃ๓ ด๓ ฟ (@PatientScot)Photo by Patient Scot Invests ๐Ÿด๓ ง๓ ข๓ ณ๓ ฃ๓ ด๓ ฟ (@PatientScot)Photo by Patient Scot Invests ๐Ÿด๓ ง๓ ข๓ ณ๓ ฃ๓ ด๓ ฟ (@PatientScot)Photo by Patient Scot Invests ๐Ÿด๓ ง๓ ข๓ ณ๓ ฃ๓ ด๓ ฟ (@PatientScot)Photo by Patient Scot Invests ๐Ÿด๓ ง๓ ข๓ ณ๓ ฃ๓ ด๓ ฟ (@PatientScot)Photo by Patient Scot Invests ๐Ÿด๓ ง๓ ข๓ ณ๓ ฃ๓ ด๓ ฟ (@PatientScot)Photo by Patient Scot Invests ๐Ÿด๓ ง๓ ข๓ ณ๓ ฃ๓ ด๓ ฟ (@PatientScot)Photo by Patient Scot Invests ๐Ÿด๓ ง๓ ข๓ ณ๓ ฃ๓ ด๓ ฟ (@PatientScot)Photo by Patient Scot Invests ๐Ÿด๓ ง๓ ข๓ ณ๓ ฃ๓ ด๓ ฟ (@PatientScot)
Portfolio Update โค๏ธ Been a solid few months since the last update. Thanks to $ASST which I sold for over 100% gain. Still holding $BMNR for crypto exposure but will happily get back in Strive when it cools down. More than doubled my position in $GRAB and have added $FSLR, $APP, $RKLB $UBER and $KRKNF recently. Will be exiting $FUBO after next earnings if nothing changes fundamentally. A few of these names are swings like $WING and my highest conviction positions are $RDDT, $SOFI and $OSCR. My SIPP if anyone is interested contains $MOD and $NOK I reduced data centre exposure ($KEEL and $IREN) as charts felt like they were going lower but happy to split my data centre weighting across these two names equally if we get some discounts to load up some more. Much love and let's keep growing ๐Ÿ’—
Portfolio Update โค๏ธ July was a crazy month, had $IREN and $CRWV -30% and bought more for it to rocket back and $CRWV is currently green $ZETA has helped bump this up after great earnings and trimmed $OSCR and $ELF recently too. $NVO my stop loss hit after the surprise earnings the day before it was due but after reviewing I'm not against jumping back in just above my previous cost basis will just let the dust settle first. Still bullish. Added $LEU as a nuclear play, $CELH, $NFLX for a swing and sold out of $ADBE Let me know if you'd like to see my positions and their gains/losses โœŒ๏ธ
2
653
$GRAB that upper wick to the top of the trend line is sickening. Will happily wait for that gap to fill to load some more though, always a silver lining
2
147
Ten Hag to Amorim to Carrick to Pochettino How the mighty have fallen
1
2
78
We're just doing the rounds, over to $NBIS to report then we can get started again. Just need to make sure no one has shit the bed $IREN $CRWV
230
Sacking Jensen would be like cutting your knob off to spite your face $NVDA
1
91
Maybe if $HIMS goes low enough, it could legit be a 10x opportunity. 10x at $5 is quite possible by 2030
112
Haven't had my indicator's weekly orange signal on $NVDA since 2022. Make of that what you will, its either the end or one hell of a dip! I'm buying, NFA
77
$OSCR like a beach ball underwater, just won't stay down. Coming soon though... I hope
81
Better r/r at that range, but not something I'd ever touch barring a swing perhaps
Sorry boner pill bros, Andrew Huberman isn't saving this $HIMS chart. I'll see you down between $12-$15.
1
51
Just a reminder that $RDDT dau dropped a ball hair lower for users who don't contribute to the arpu and $HIMS lose 103k paying subscribers, let's see a 30% drop boys ๐Ÿ’ฐ
$HIMS just lost 103.000 subscribers QoQ... They are down another 1% after earnings, after already dropping 11% earlier today. They just reported a double miss. I can live with the revenue miss, as they still grew 49% YoY, which I think is great. The EPS miss is partly due to their lower margins as they try to gain customers in the GLP-1 market, which I think is great. But losing 103,000 subscribers QoQ is not a good look. Management also reduced their full-year Adjusted EBITDA outlook to $257โ€“$277 million to account for their strategic pivots and planned Q4 platform expansions. On top of that the company posted a $33 million net loss compared to a $15.8 million profit last year, heavily impacted by restructuring charges tied to their U.S. weight-loss strategic shift Honestly, very disappointed with these results. Not much good to take away from this.
1
259
$NVDA closing above the AVWAP low... Just because Jensen done wrong in Hong Kong doesn't mean you can't go long long
1
99